Holen Sie sich die Stockscreener-App
15.04
2.65%
-0.41
Vorhandelsmarkt:
15.90
0.86
+5.72%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt CC?
Forum
Prognose
Dividendenhistorie
Schlusskurs vom Vortag:
$15.45
Offen:
$15.6
24-Stunden-Volumen:
1.74M
Relative Volume:
0.70
Marktkapitalisierung:
$2.26B
Einnahmen:
$5.82B
Nettoeinkommen (Verlust:
$-411.00M
KGV:
-5.4973
EPS:
-2.7359
Netto-Cashflow:
$154.00M
1W Leistung:
-4.08%
1M Leistung:
-4.51%
6M Leistung:
-13.66%
1J Leistung:
-9.78%
1-Tages-Spanne:
$15.03
$15.62
1-Wochen-Bereich:
$15.03
$15.81
52-Wochen-Spanne:
$10.44
$28.67
Citigroup Inc Stock (CC) Company Profile
Firmenname
Citigroup Inc
Sektor
Branche
Telefon
302 773 1000
Adresse
1007 MARKET STREET, WILMINGTON, DE
Compare CC vs JPM, BAC, HSBC, RY, WFC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CC
Citigroup Inc
|
15.04 | 2.33B | 5.82B | -411.00M | 154.00M | -2.7359 |
JPM
Jpmorgan Chase Co
|
354.71 | 939.70B | 297.42B | 64.78B | 148.32B | 23.34 |
BAC
Bank Of America Corp
|
62.67 | 436.28B | 194.43B | 33.77B | 64.54B | 4.3483 |
HSBC
Hsbc Holdings Plc Adr
|
105.11 | 363.93B | 133.80B | 21.76B | 105.99B | 6.0511 |
RY
Royal Bank Of Canada
|
206.81 | 289.35B | 99.69B | 16.04B | 26.84B | 11.15 |
WFC
Wells Fargo Co
|
89.67 | 265.99B | 128.92B | 22.97B | -2.35B | 6.8796 |
Citigroup Inc Stock (CC) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-03-27 | Hochstufung | Mizuho | Neutral → Outperform |
| 2025-01-28 | Eingeleitet | Truist | Buy |
| 2024-07-09 | Hochstufung | UBS | Neutral → Buy |
| 2024-06-07 | Eingeleitet | Mizuho | Neutral |
| 2024-04-09 | Hochstufung | BMO Capital Markets | Underperform → Outperform |
| 2024-03-05 | Herabstufung | UBS | Buy → Neutral |
| 2024-02-29 | Herabstufung | BMO Capital Markets | Outperform → Underperform |
| 2023-12-01 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2023-06-22 | Herabstufung | BofA Securities | Buy → Neutral |
| 2023-01-24 | Hochstufung | UBS | Neutral → Buy |
| 2023-01-11 | Hochstufung | BofA Securities | Neutral → Buy |
| 2023-01-10 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2022-11-01 | Eingeleitet | Credit Suisse | Underperform |
| 2022-10-13 | Eingeleitet | Goldman | Neutral |
| 2022-10-05 | Herabstufung | Argus | Buy → Hold |
| 2022-06-14 | Herabstufung | BofA Securities | Buy → Neutral |
| 2021-06-10 | Eingeleitet | Wolfe Research | Outperform |
| 2021-06-09 | Hochstufung | Goldman | Neutral → Buy |
| 2021-05-20 | Eingeleitet | BofA Securities | Buy |
| 2021-05-06 | Hochstufung | Argus | Hold → Buy |
| 2021-01-08 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2020-12-04 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2020-11-30 | Eingeleitet | Alembic Global Advisors | Overweight |
| 2020-03-23 | Herabstufung | Jefferies | Buy → Hold |
| 2020-02-14 | Hochstufung | CFRA | Buy → Strong Buy |
| 2019-11-06 | Hochstufung | CFRA | Hold → Buy |
| 2019-08-20 | Hochstufung | Susquehanna | Neutral → Positive |
| 2019-08-09 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2019-08-06 | Herabstufung | Argus | Buy → Hold |
| 2019-08-05 | Herabstufung | SunTrust | Buy → Hold |
| 2019-07-12 | Herabstufung | Citigroup | Buy → Neutral |
| 2019-05-06 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2019-04-15 | Hochstufung | SunTrust | Hold → Buy |
| 2019-02-19 | Herabstufung | Susquehanna | Positive → Neutral |
| 2019-01-08 | Eingeleitet | HSBC Securities | Buy |
| 2019-01-04 | Hochstufung | Citigroup | Neutral → Buy |
| 2018-11-02 | Herabstufung | Citigroup | Buy → Neutral |
| 2018-07-18 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2018-01-30 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2017-12-06 | Herabstufung | Goldman | Buy → Neutral |
| 2017-08-07 | Hochstufung | UBS | Sell → Neutral |
Alle ansehen
Citigroup Inc Aktie (CC) Neueste Nachrichten
Citigroup (C) Gains on Turnaround Momentum - Yahoo Finance
Form 8K Citigroup For: 10 September By Investing.com - Investing.com UK
Citigroup Upgrades UiPath (NYSE:PATH) to "Strong-Buy" - MarketBeat
Nordnet AB And Citigroup Inc. Launch Research Portal Giving Savers Access To Research - marketscreener.com
Citigroup Inc. $C Shares Acquired by Tidal Investments LLC - MarketBeat
Citigroup Adjusts Price Target on Boston Scientific to $57 From $61, Keeps Buy Rating - marketscreener.com
Citigroup Inc. $C Position Trimmed by National Pension Service - MarketBeat
WINTON GROUP Ltd Has $11.44 Million Holdings in Citigroup Inc. $C - MarketBeat
Integrated Wealth Concepts LLC Sells 10,009 Shares of Citigroup Inc. $C - MarketBeat
Engineers Gate Manager LP Lowers Stake in Citigroup Inc. $C - MarketBeat
BlueCrest Capital Management Ltd Reduces Holdings in Citigroup Inc. $C - MarketBeat
Citigroup stock heads into the open after a 1.0 percent gain - ad-hoc-news.de
Citigroup Becomes Substantial Shareholder in Lotus Resources with 5.08% Stake - Kalkine
BioAge at Citi biopharma summit: pivot to eye disease and new targets - Investing.com Canada
Citigroup's Private Bank Hires Radzinski From Bank Of America - marketscreener.com
Veradermics at citigroup summit: oral hair-loss drug nears key data - Investing.com
Citi Private Bank hires Radzinski from Bank of America - WTVB
Akamai Technologies Jumps 5.3% After Citigroup Maintains Neutral - news.alphastreet.com
Transcript : Cytokinetics, Incorporated Presents at Citigroup?s Biopharma Back to School Summit 2026, Sep-09-2026 03:00 PM - marketscreener.com
Beam Therapeutics at Citi summit: platform gains momentum across pipeline By Investing.com - Investing.com Canada
Citigroup : Citi First Quarter, Second Quarter, Third Quarter and Fourth Quarter 2027 Earnings Calls - marketscreener.com
LULU Maintained by Citigroup -- Price Target Lowered to $117.00 - GuruFocus
Cytokinetics at citigroup summit: hcm expansion drives growth hopes By Investing.com - Investing.com India
Cytokinetics at citigroup summit: hcm expansion drives growth hopes - Investing.com
Transcript : Protagonist Therapeutics, Inc. Presents at Citigroup?s Biopharma Back to School Summit 2026, Sep-09-2026 10 - marketscreener.com
Transcript : Beam Therapeutics Inc. Presents at Citigroup?s Biopharma Back to School Summit 2026, Sep-09-2026 01 - marketscreener.com
Lexicon Pharmaceuticals at Citi summit: hcm data, t1d reset - Investing.com
Transcript : Spyre Therapeutics, Inc. Presents at Citigroup?s Biopharma Back to School Summit 2026, Sep-09-2026 10 - marketscreener.com
Ollie’s Bargain Outlet Holdings Drops 5.7% After Citigroup Maintains Buy - news.alphastreet.com
Learn Why The Bull Case For Citi Stock Could Change Following China Brokerage Approval - simplywall.st
Transcript : BioAge Labs, Inc. Presents at Citigroup?s Biopharma Back to School Summit 2026, Sep-09-2026 11 - marketscreener.com
Vor Biopharma at Citigroup’s biopharma back to school summit: pipeline push By Investing.com - Investing.com Canada
Nuvation Bio at citigroup biopharma summit: growth rests on three pillars - Investing.com India
Lexicon Pharmaceuticals at Citi summit: hcm data, t1d reset By Investing.com - Investing.com UK
Transcript : Celcuity Inc. Presents at Citigroup?s Biopharma Back to School Summit 2026, Sep-09-2026 08 - marketscreener.com
Transcript : Allogene Therapeutics, Inc. Presents at Citigroup?s Biopharma Back to School Summit 2026, Sep-09-2026 08 - marketscreener.com
Arcus Biosciences at Citi summit: casdatifan data loom large By Investing.com - Investing.com Canada
Transcript : EyePoint, Inc. Presents at Citigroup?s Biopharma Back to School Summit 2026, Sep-09-2026 08 - marketscreener.com
Arcturus Therapeutics at Citi summit: two catalysts, one pivotal year - Investing.com
Jade Biosciences at citigroup summit: fast-track bet on igan By Investing.com - Investing.com UK
Citigroup Adjusts Stryker Price Target to $360 From $399, Maintains Buy Rating - marketscreener.com
Exelixis at Citigroup summit: building a second growth engine - Investing.com
Is It Worth Investing in Citigroup (C) Based on Wall Street's Bullish Views? - Yahoo Finance
Allogene at Citi summit: mrD strategy and cash runway in focus - Investing.com
EyePoint at Citi summit: wet AMD setback, but path stays open - Investing.com India
Form FWP CITIGROUP INC Filed by: CITIGROUP INC - StreetInsider
Form FWP Citigroup Global Markets Filed by: Citigroup Global Markets Holdings Inc. - StreetInsider
Capital Analysts LLC Lowers Stock Holdings in Citigroup Inc. $C - MarketBeat
Goldman Sachs Adjusts Price Target on Citigroup to $175 From $161, Keeps Buy Rating - marketscreener.com
Waverly Advisors LLC Sells 21,044 Shares of Citigroup Inc. $C - MarketBeat
Citigroup's Restructuring Is Working, And Valuation Has Not Caught Up (NYSE:C) - Seeking Alpha
Finanzdaten der Citigroup Inc-Aktie (CC)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.42%
0.78%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):